|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales (to related parties $1,266 and $1,766 for the year ended December 31, 2025 and 2024, respectively) | |||||
| Cost of sales (derived from related party net sales $863 and $1,304 for the year ended December 31, 2025 and 2024, respectively) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Amortization of intangible assets | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense (from related parties $7,729 and $4,680 for the year ended December 31, 2023 and 2022, respectively) | |||||
| Other expense (income), net | |||||
| Interest expense (from related parties $634 and $6,998 for the year ended December 31, 2025 and 2024, respectively) | |||||
| Other expense (income) | |||||
| Total other expense, net | |||||
| Income before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net income | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Earnings per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
Loading...
